These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8272803)

  • 1. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating HIV education and counseling into routine prenatal care: a program model.
    Mason J; Preisinger J; Sperling R; Walther V; Berrier J; Evans V
    AIDS Educ Prev; 1991; 3(2):118-23. PubMed ID: 1873135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989.
    Robert CF; Déglon JJ; Wintsch J; Martin JL; Perrin L; Bourquin M; Gabriel V; Hirschel B
    AIDS; 1990 Jul; 4(7):657-60. PubMed ID: 2397058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-positive drug addicts treated at the Copenhagen City Drug Dependency Clinic 1986-1992].
    Hjorther AB; Andersen LB; Hetmar O; Jepsen PW
    Ugeskr Laeger; 1994 May; 156(20):3028-32. PubMed ID: 8023410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.
    Franken IH; Kaplan CD
    AIDS Educ Prev; 1997 Apr; 9(2):161-80. PubMed ID: 9167801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of treatment with methadone on utilization of medical care by addicts seropositive for the AIDS virus. Results of a descriptive study, Bayonne, 1996].
    Lafitte C; Bonnal F; Daulouede JP; Tignol J
    Encephale; 1998; 24(3):205-14. PubMed ID: 9696913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical and psychosocial effects of methadone substitution in HIV infected substance-dependent patients].
    Walger P; Baumgart P; Wilke G; Kupfer U; von Eiff M; Dorst KG
    Psychother Psychosom Med Psychol; 1989 Nov; 39(11):381-9. PubMed ID: 2587688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Health Project.
    Farrell J
    Newsline People AIDS Coalit N Y; 1998 Jun; ():18-20. PubMed ID: 11367468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal social networks and HIV status among women on methadone.
    el-Bassel N; Cooper DK; Chen DR; Schilling RF
    AIDS Care; 1998 Dec; 10(6):735-49. PubMed ID: 9924528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV risk behavior, street outreach, and condom use in eight high-risk populations.
    Anderson JE; Cheney R; Clatts M; Faruque S; Kipke M; Long A; Mills S; Toomey K; Wiebel W
    AIDS Educ Prev; 1996 Jun; 8(3):191-204. PubMed ID: 8806949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.
    McNeely J; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2006 Jul; 31(1):51-7. PubMed ID: 16814010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study.
    Nemoto T; Brown LS; Primm BJ; Foster K; Chu A
    NIDA Res Monogr; 1989; 95():407-8. PubMed ID: 2641011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.